{"id":123037,"date":"2021-11-16T22:31:46","date_gmt":"2021-11-16T22:31:46","guid":{"rendered":"https:\/\/fin2me.com\/?p=123037"},"modified":"2021-11-16T22:31:46","modified_gmt":"2021-11-16T22:31:46","slug":"cdc-advisers-to-review-data-on-wider-use-of-pfizer-biontech-covid-19-vaccine","status":"publish","type":"post","link":"https:\/\/fin2me.com\/markets\/cdc-advisers-to-review-data-on-wider-use-of-pfizer-biontech-covid-19-vaccine\/","title":{"rendered":"CDC advisers to review data on wider use of Pfizer-BioNTech COVID-19 vaccine"},"content":{"rendered":"<figcaption>FILE PHOTO: A general view of the U.S. Centers for Disease Control and Prevention (CDC) headquarters in Atlanta, Georgia September 30, 2014.  REUTERS\/Tami Chappell<\/figcaption><p>(Reuters) &#8211; A U.S. Centers for Disease Control and Prevention (CDC) advisory panel will meet on Friday to discuss expanding the eligibility for booster doses of Pfizer and partner BioNTech\u2019s COVID-19 vaccine, currently allowed for select groups of people.<\/p>\n<p>Earlier this month, Pfizer had requested the U.S. Food and Drug Administration (FDA) to authorize booster doses of the vaccine in all adults, presenting recent data showing the shot would help prevent disease across ages.<\/p>\n<p>The company\u2019s third dose has been authorized for immunocompromised individuals, people aged 65 and above, all those at high risk of severe disease, and people who are regularly exposed to the virus.<\/p>\n<p>U.S. President Joe Biden\u2019s administration in August announced plans to roll out booster doses for all adults in September.<\/p>\n<p>The CDC sets U.S. adult and childhood immunization schedules based on recommendations from the Advisory Committee on Immunization Practices.<\/p>\n<p>Source: <a href=\"https:\/\/www.reuters.com\/article\/us-health-coronavirus-boosters-cdc\/cdc-advisers-to-review-data-on-wider-use-of-pfizer-biontech-covid-19-vaccine-idUSKBN2I12G1\" target=\"_blank\" rel=\"noopener\">Read Full Article<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>FILE PHOTO: A general view of the U.S. Centers for Disease Control and Prevention (CDC) headquarters in Atlanta, Georgia September 30, 2014. REUTERS\/Tami Chappell(Reuters) &#8211; [&#8230;]<\/p>\n","protected":false},"author":3,"featured_media":123036,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v21.7 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>CDC advisers to review data on wider use of Pfizer-BioNTech COVID-19 vaccine - Fin2me<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/fin2me.com\/markets\/cdc-advisers-to-review-data-on-wider-use-of-pfizer-biontech-covid-19-vaccine\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"CDC advisers to review data on wider use of Pfizer-BioNTech COVID-19 vaccine - Fin2me\" \/>\n<meta property=\"og:description\" content=\"FILE PHOTO: A general view of the U.S. Centers for Disease Control and Prevention (CDC) headquarters in Atlanta, Georgia September 30, 2014. REUTERS\/Tami Chappell(Reuters) &#8211; [...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/fin2me.com\/markets\/cdc-advisers-to-review-data-on-wider-use-of-pfizer-biontech-covid-19-vaccine\/\" \/>\n<meta property=\"og:site_name\" content=\"Fin2me\" \/>\n<meta property=\"article:published_time\" content=\"2021-11-16T22:31:46+00:00\" \/>\n<meta name=\"author\" content=\"Mark\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:image\" content=\"https:\/\/fin2me.com\/wp-content\/uploads\/2021\/11\/CDC-advisers-to-review-data-on-wider-use-of-Pfizer-BioNTech-COVID-19-vaccine.jpg\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Mark\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/fin2me.com\/markets\/cdc-advisers-to-review-data-on-wider-use-of-pfizer-biontech-covid-19-vaccine\/\",\"url\":\"https:\/\/fin2me.com\/markets\/cdc-advisers-to-review-data-on-wider-use-of-pfizer-biontech-covid-19-vaccine\/\",\"name\":\"CDC advisers to review data on wider use of Pfizer-BioNTech COVID-19 vaccine - Fin2me\",\"isPartOf\":{\"@id\":\"https:\/\/fin2me.com\/#website\"},\"datePublished\":\"2021-11-16T22:31:46+00:00\",\"dateModified\":\"2021-11-16T22:31:46+00:00\",\"author\":{\"@id\":\"https:\/\/fin2me.com\/#\/schema\/person\/ad0e9920e03d3b41c7ad02a18375d76a\"},\"breadcrumb\":{\"@id\":\"https:\/\/fin2me.com\/markets\/cdc-advisers-to-review-data-on-wider-use-of-pfizer-biontech-covid-19-vaccine\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/fin2me.com\/markets\/cdc-advisers-to-review-data-on-wider-use-of-pfizer-biontech-covid-19-vaccine\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/fin2me.com\/markets\/cdc-advisers-to-review-data-on-wider-use-of-pfizer-biontech-covid-19-vaccine\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/fin2me.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Markets\",\"item\":\"https:\/\/fin2me.com\/category\/markets\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"CDC advisers to review data on wider use of Pfizer-BioNTech COVID-19 vaccine\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/fin2me.com\/#website\",\"url\":\"https:\/\/fin2me.com\/\",\"name\":\"Fin2me\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/fin2me.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/fin2me.com\/#\/schema\/person\/ad0e9920e03d3b41c7ad02a18375d76a\",\"name\":\"Mark\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/fin2me.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/39b72719fb75a2d3c7d7695026648602?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/39b72719fb75a2d3c7d7695026648602?s=96&d=mm&r=g\",\"caption\":\"Mark\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"CDC advisers to review data on wider use of Pfizer-BioNTech COVID-19 vaccine - Fin2me","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/fin2me.com\/markets\/cdc-advisers-to-review-data-on-wider-use-of-pfizer-biontech-covid-19-vaccine\/","og_locale":"en_US","og_type":"article","og_title":"CDC advisers to review data on wider use of Pfizer-BioNTech COVID-19 vaccine - Fin2me","og_description":"FILE PHOTO: A general view of the U.S. Centers for Disease Control and Prevention (CDC) headquarters in Atlanta, Georgia September 30, 2014. REUTERS\/Tami Chappell(Reuters) &#8211; [...]","og_url":"https:\/\/fin2me.com\/markets\/cdc-advisers-to-review-data-on-wider-use-of-pfizer-biontech-covid-19-vaccine\/","og_site_name":"Fin2me","article_published_time":"2021-11-16T22:31:46+00:00","author":"Mark","twitter_card":"summary_large_image","twitter_image":"https:\/\/fin2me.com\/wp-content\/uploads\/2021\/11\/CDC-advisers-to-review-data-on-wider-use-of-Pfizer-BioNTech-COVID-19-vaccine.jpg","twitter_misc":{"Written by":"Mark","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/fin2me.com\/markets\/cdc-advisers-to-review-data-on-wider-use-of-pfizer-biontech-covid-19-vaccine\/","url":"https:\/\/fin2me.com\/markets\/cdc-advisers-to-review-data-on-wider-use-of-pfizer-biontech-covid-19-vaccine\/","name":"CDC advisers to review data on wider use of Pfizer-BioNTech COVID-19 vaccine - Fin2me","isPartOf":{"@id":"https:\/\/fin2me.com\/#website"},"datePublished":"2021-11-16T22:31:46+00:00","dateModified":"2021-11-16T22:31:46+00:00","author":{"@id":"https:\/\/fin2me.com\/#\/schema\/person\/ad0e9920e03d3b41c7ad02a18375d76a"},"breadcrumb":{"@id":"https:\/\/fin2me.com\/markets\/cdc-advisers-to-review-data-on-wider-use-of-pfizer-biontech-covid-19-vaccine\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/fin2me.com\/markets\/cdc-advisers-to-review-data-on-wider-use-of-pfizer-biontech-covid-19-vaccine\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/fin2me.com\/markets\/cdc-advisers-to-review-data-on-wider-use-of-pfizer-biontech-covid-19-vaccine\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/fin2me.com\/"},{"@type":"ListItem","position":2,"name":"Markets","item":"https:\/\/fin2me.com\/category\/markets\/"},{"@type":"ListItem","position":3,"name":"CDC advisers to review data on wider use of Pfizer-BioNTech COVID-19 vaccine"}]},{"@type":"WebSite","@id":"https:\/\/fin2me.com\/#website","url":"https:\/\/fin2me.com\/","name":"Fin2me","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/fin2me.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/fin2me.com\/#\/schema\/person\/ad0e9920e03d3b41c7ad02a18375d76a","name":"Mark","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/fin2me.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/39b72719fb75a2d3c7d7695026648602?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/39b72719fb75a2d3c7d7695026648602?s=96&d=mm&r=g","caption":"Mark"}}]}},"_links":{"self":[{"href":"https:\/\/fin2me.com\/wp-json\/wp\/v2\/posts\/123037"}],"collection":[{"href":"https:\/\/fin2me.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/fin2me.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/fin2me.com\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/fin2me.com\/wp-json\/wp\/v2\/comments?post=123037"}],"version-history":[{"count":0,"href":"https:\/\/fin2me.com\/wp-json\/wp\/v2\/posts\/123037\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/fin2me.com\/wp-json\/wp\/v2\/media\/123036"}],"wp:attachment":[{"href":"https:\/\/fin2me.com\/wp-json\/wp\/v2\/media?parent=123037"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/fin2me.com\/wp-json\/wp\/v2\/categories?post=123037"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/fin2me.com\/wp-json\/wp\/v2\/tags?post=123037"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}